About this Research Topic
We are pleased to introduce the collection Model Organisms in Respiratory Pharmacology 2023.
Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. Classically used for biomedical studies, model organisms are progressively entering many disciplines within the Respiratory Pharmacology field. This article collection will showcase studies of Model Organisms that have significance to the field of Respiratory Pharmacology as a whole.
We welcome submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Technology and Code that cover, but are not limited to, the following themes:
• Generation and characterisation of novel respiratory models (healthy and diseased)
• Advances to the use of existing respiratory models
• Application of in vitro or in vivo respiratory models in research investigations
• Animal models of genetic (e.g. cystic fibrosis) or induced lung diseases (e.g. infections, acute lung injury)
• Patient-derived models for use in disease investigations and personalized medicines
• Therapy and drug development employing respiratory models
• Reviews of respiratory models for use in specific research areas (e.g. genetic lung diseases, smoking, asthma, SARs CoV2)
Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. Classically used for biomedical studies, model organisms are progressively entering many disciplines within the Respiratory Pharmacology field. This article collection will showcase studies of Model Organisms that have significance to the field of Respiratory Pharmacology as a whole.
We welcome submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Technology and Code that cover, but are not limited to, the following themes:
• Generation and characterisation of novel respiratory models (healthy and diseased)
• Advances to the use of existing respiratory models
• Application of in vitro or in vivo respiratory models in research investigations
• Animal models of genetic (e.g. cystic fibrosis) or induced lung diseases (e.g. infections, acute lung injury)
• Patient-derived models for use in disease investigations and personalized medicines
• Therapy and drug development employing respiratory models
• Reviews of respiratory models for use in specific research areas (e.g. genetic lung diseases, smoking, asthma, SARs CoV2)
Keywords: model organisms, respiratory disease, pulmonary disease, drug discovery
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
